Comparison of 0.1% Bromfenac Sodium and 0.1% Pemirolast Potassium for the Treatment of Allergic Conj...
Comparison of 0.1% Bromfenac Sodium and 0.1% Pemirolast Potassium for the Treatment of Allergic Conjunctivitis
About this item
Full title
Author / Creator
Publisher
Japan: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Japan: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
We compared the efficacy of a new nonsteroidal antiinflammatory drug (NSAID) eye drop, 0.1% bromfenac sodium (Bromfenac), with that of an antiallergic agent, 0.1% pemirolast potassium (Pemirolast), in the treatment of seasonal allergic conjunctivitis in Japanese patients.
Twenty-two subjects with seasonal allergic conjunctivitis were enrolled in...
Alternative Titles
Full title
Comparison of 0.1% Bromfenac Sodium and 0.1% Pemirolast Potassium for the Treatment of Allergic Conjunctivitis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67177083
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67177083
Other Identifiers
ISSN
0021-5155
E-ISSN
1613-2246
DOI
10.1007/s10384-004-0127-2
